University Hospitals cardiologist explains the benefits, side effects, and future of these increasingly popular drugs.

Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug ...

The city of Springfield is following in the steps of other large employers in filing suit against manufacturers of diabetes ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

The Monterey County Health Needs Collaborative has released a list of top health needs in the county.

Medicines for obesity, diabetes, rare diseases, cancer, and women's health feature among Clarivate's annual round-up of 11 Drugs to Watch this year, but two of them far outstrip the others in sales ...

Delaware is the latest state to accuse pharmaceutical manufactures of jacking up insulin prices, even as the cost to produce diabetes medications has decreased.

Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a ...

Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

The head of the Heart Research Institute is telling young scientists medical research is a “terrible career path”. There’s a ...

On January 12, Victoria Greene, Founding Partner and CIO at G Squared Private Wealth, joined CNBC to discuss her current ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity ...